CONNECT1905: Treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma

CONNECT1905: Treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma

Es posible que algunos contenidos no estén disponibles en español.

Study Details

Full Title

CONNECT1905: Phase 2 Study of Systemic IL-6 Receptor Antagonist ACTEMRA® (tocilizumab) for the treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma

Principal Investigator

Daniel
Landi

Protocol Number

PRO00113161

NCT ID

NCT05233397

Phase

II

Enrollment Status

Open to Enrollment
ClinicalTrials.gov